Holocene Advisors’s Edwards Lifesciences EW Stock Holding History

Holocene Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-703,600	Closed	-$82.8M	–	877
2022 Q1	$82.8M	Buy	+703,600	New	+$78.9M	0.43%	73
2021 Q4	–	Sell	-279,000	Closed	-$31.6M	–	897
2021 Q3	$31.6M	Sell	279,000 -333,500	-54%	-$38.1M	0.17%	163
2021 Q2	$63.4M	Buy	+612,500	New	+$57.7M	0.36%	101

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Holocene Advisors's EW Position: Q1 2026 in Review

Holocene Advisors reduced its Edwards Lifesciences (EW) stake by 67% in Q1 2026, selling an estimated $125M and leaving 738,099 shares worth $59.1M. The position accounts for 0.14% of the portfolio, ranked #169.

Holocene Advisors first reported a position in EW in Q4 2017 and has held it in 27 quarters since. The position peaked at $369M in Q3 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Holocene Advisors held 738,099 shares of Edwards Lifesciences worth $59.1M as of Q1 2026.
Holocene Advisors sold 1,512,944 Edwards Lifesciences shares in Q1 2026, an estimated $125M.
Edwards Lifesciences made up 0.14% of Holocene Advisors's portfolio in Q1 2026, its #169 holding.
Holocene Advisors first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 27 quarters since.
Holocene Advisors's Edwards Lifesciences position peaked at $369M in Q3 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.